ProCE Banner Activity

Key HIV Studies Influencing My Practice Following IAS 2023—Dr Chloe Orkin

Video

Hear from expert faculty as they present their insights on some of the most clinically relevant new data presented at IAS 2023, including HIV treatment—such as data in pregnant persons and vulnerable populations with complex needs, and studies on ART-related weight gain—and prevention strategies for HIV, and tuberculosis and cardiovascular disease among persons living with HIV.

Released: August 09, 2023

Share

Faculty

Chloe Orkin

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc., Janssen Therapeutics, Division of Janssen Products, LP, ViiV Healthcare

Gilead Sciences, Inc.

Janssen Therapeutics, Division of Janssen Products, LP

ViiV Healthcare

Partners

IAS 2023

ProCE Banner

Target Audience

This program is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for patients with or at risk of HIV infection.

Program Learning Goal

The goal of this program is to improve the knowledge and competence of learners at applying new findings to optimize treatment for patients with HIV

Disclosure

Primary Author

Chloe Orkin, MBChB, FRCP, MD

Professor of Infection and Inequities
Dean for Healthcare Transformation
Queen Mary University of London
Faculty of Medicine and Dentistry
London, United Kingdom

Chloe Orkin, MBChB, FRCP, MD: consultant/advisor/speaker: Gilead Sciences, GSK, MSD, ViiV Healthcare; researcher: AstraZeneca, Gilead Sciences, GSK, MSD, ViiV Healthcare.

Format

This program has been made available online.